1-20 of 28
Authors: Subodh Verma
Save search
Sort by
Journal Article

Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial

PDF
Michael Böhm and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1304–1317, https://doi.org/10.1093/eurheartj/ehae938
Published: 04 March 2025
Journal Article

Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide Get access

PDF
Subodh Verma and others
European Heart Journal, Volume 46, Issue 12, 21 March 2025, Pages 1109–1111, https://doi.org/10.1093/eurheartj/ehae744
Published: 14 December 2024
Journal Article
EDITOR'S CHOICE

Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction Get access

PDF
Nikolaus Marx and others
European Heart Journal, Volume 45, Issue 48, 21 December 2024, Pages 5117–5126, https://doi.org/10.1093/eurheartj/ehae533
Published: 10 October 2024
Journal Article

Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

PDF
Sanjiv J Shah and others
European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3254–3269, https://doi.org/10.1093/eurheartj/ehae322
Published: 13 May 2024
Journal Article

The cardiovascular effects of novel weight loss therapies

PDF
Muhammad Shariq Usman and others
European Heart Journal, Volume 44, Issue 48, 21 December 2023, Pages 5036–5048, https://doi.org/10.1093/eurheartj/ehad664
Published: 15 November 2023
Journal Article

Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction

PDF
Arjun K Pandey and others
European Heart Journal, Volume 44, Issue 37, 1 October 2023, Pages 3640–3651, https://doi.org/10.1093/eurheartj/ehad389
Published: 07 September 2023
Journal Article

Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table

PDF
Francesco Cosentino and others
European Heart Journal, Volume 44, Issue 39, 14 October 2023, Pages 4141–4156, https://doi.org/10.1093/eurheartj/ehad445
Published: 14 July 2023
Journal Article

The year in cardiovascular medicine 2022: the top 10 papers in diabetes and metabolic disorders

PDF
Francesco Cosentino and others
European Heart Journal, Volume 44, Issue 6, 7 February 2023, Pages 448–451, https://doi.org/10.1093/eurheartj/ehac780
Published: 02 January 2023
Journal Article

Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease

PDF
Arjun K Pandey and others
European Heart Journal, Volume 43, Issue 31, 14 August 2022, Pages 2931–2945, https://doi.org/10.1093/eurheartj/ehac299
Published: 17 June 2022
Journal Article

Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure

PDF
Subodh Verma and others
European Heart Journal, Volume 43, Issue 31, 14 August 2022, Pages 2994–2996, https://doi.org/10.1093/eurheartj/ehac304
Published: 10 June 2022
Journal Article

The year in cardiovascular medicine 2021: diabetes and metabolic disorders

PDF
Francesco Cosentino and others
European Heart Journal, Volume 43, Issue 4, 21 January 2022, Pages 263–270, https://doi.org/10.1093/eurheartj/ehab876
Published: 03 January 2022
Journal Article

Ambient temperature and aortic dissection: do pipes burst in freezing weather?

PDF
Makoto Hibino and others
European Heart Journal, Volume 43, Issue 3, 14 January 2022, Pages 236–238, https://doi.org/10.1093/eurheartj/ehab792
Published: 29 November 2021
Journal Article

Vascular repair and regeneration in cardiometabolic diseases

PDF
David A Hess and others
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 450–459, https://doi.org/10.1093/eurheartj/ehab758
Published: 24 November 2021
Journal Article

Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights

PDF
Naveed Sattar and others
European Heart Journal, Volume 43, Issue 31, 14 August 2022, Pages 2968–2970, https://doi.org/10.1093/eurheartj/ehab709
Published: 07 October 2021
Journal Article

Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

PDF
Carolyn S P Lam and others
European Heart Journal, Volume 42, Issue 43, 14 November 2021, Pages 4442–4451, https://doi.org/10.1093/eurheartj/ehab360
Published: 29 June 2021
Journal Article

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

PDF
Javed Butler and others
European Heart Journal, Volume 42, Issue 13, 1 April 2021, Pages 1203–1212, https://doi.org/10.1093/eurheartj/ehaa1007
Published: 09 January 2021
Journal Article

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

PDF
Matteo Serenelli and others
European Heart Journal, Volume 41, Issue 36, 21 September 2020, Pages 3402–3418, https://doi.org/10.1093/eurheartj/ehaa496
Published: 21 August 2020
Journal Article

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

PDF
Stefan D Anker and others
European Heart Journal, Volume 41, Issue 22, 7 June 2020, Pages 2109–2117, https://doi.org/10.1093/eurheartj/ehaa461
Published: 04 June 2020
Journal Article
EDITOR'S CHOICE

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

PDF
Kieran F Docherty and others
European Heart Journal, Volume 41, Issue 25, 1 July 2020, Pages 2379–2392, https://doi.org/10.1093/eurheartj/ehaa183
Published: 28 March 2020
Journal Article
EDITOR'S CHOICE

Targeting cardiovascular inflammation: next steps in clinical translation Get access

PDF
Patrick R Lawler and others
European Heart Journal, Volume 42, Issue 1, 1 January 2021, Pages 113–131, https://doi.org/10.1093/eurheartj/ehaa099
Published: 16 March 2020